Gisela Paulsen - 15 Aug 2022 Form 4 Insider Report for Oncocyte Corp (OCX)

Role
President & COO
Signature
/s/ Gisela Paulsen
Issuer symbol
OCX
Transactions as of
15 Aug 2022
Net transactions value
$0
Form type
4
Filing time
17 Aug 2022, 20:22:58 UTC
Previous filing
17 Mar 2022
Next filing
20 Dec 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OCX Common Stock, no par value Award $0 +175,000 +1061% $0.000000 191,500 15 Aug 2022 Direct F1
transaction OCX Common Stock, no par value Award $0 +350,000 +183% $0.000000 541,500 15 Aug 2022 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Restricted Stock Units shall vest one year from the date of grant, subject to the Reporting Person's continued service from the date of grant until the vesting date.
F2 The Restricted Stock Units shall vest on January 1, 2024 based on the achievement of a pre-determined financial objective related to the Issuer's available cash.